Johnson & Johnson

🚨 Reasons for Boycotting Johnson & Johnson

Johnson & Johnson (J&J) is the world's largest healthcare company, owning iconic brands such as Tylenol, Neutrogena, Band-Aid, Listerine, and Johnson's Baby. While the company does not sell weapons directly, it is deeply embedded in israil's security and military infrastructure through six israeli subsidiaries, production of biological defense products, billion-dollar wartime acquisitions, technology partnerships with Unit 8200-linked cyber firms, and public statements from its former VP supporting genocide. Additionally, its largest shareholders - Vanguard and BlackRock - are among the largest investors in the weapons companies supplying the israeli occupation military.

1. Six israeli Subsidiaries and Over 1,000 Employees: Johnson & Johnson maintains a direct operational presence in israil through at least six subsidiaries, including J-C Health Care Ltd., ColBar LifeScience Ltd., Biosense Webster (israel) Ltd., Intratech Medical Ltd., Orthospin Ltd., and Omrix Biopharmaceuticals Ltd. J&J opened its first operating company in israil in 1996 and now employs over 1,000 employees across four sub-companies. J&J owns facilities in Yokneam, Tel Hashomer, and Caesarea, engaging in R&D and commercial activities across pharmaceutical, medical device, and consumer health segments.OpenIntel: Johnson & Johnson — Military AuditOpenIntel: Johnson & Johnson — Political Audit
2. Biodefense Production via Omrix: Through its wholly-owned subsidiary Omrix Biopharmaceuticals, J&J manufactures plasma-derived immunoglobulins in israil, including biodefense products such as Vaccinia Immune Globulin (VIGIV) - a smallpox countermeasure reliant on israeli donor plasma, historically primarily IDF recruits. By controlling the supply of the antidote required to safely execute a mass vaccination campaign, J&J effectively underwrites israil's biological deterrence capabilities. Omrix's primary manufacturing facility is physically located within the Sheba Medical Center complex in Tel Hashomer, sharing critical utilities with the Magen David Adom National Blood Services Center - the entity statutorily responsible for supplying blood to the IDF during wartime. Omrix also maintains a manufacturing footprint in the Har Hotzvim High-Tech Park in Occupied East Jerusalem, meaning J&J pays municipal taxes to the Jerusalem Municipality and participates in the economic normalization of the settlement enterprise.OpenIntel: Johnson & Johnson — Executive Dossier (Omrix VIGIV, Sheba Medical Center, Har Hotzvim)OpenIntel: Johnson & Johnson — Economic Audit
3. $1.7 Billion V-Wave Acquisition During Gaza War: In August 2024, J&J completed its acquisition of israeli company V-Wave Ltd. for $1.7 billion ($600 million upfront + $1.1 billion in milestone payments), representing J&J's largest acquisition in israil. The deal occurred during the height of the israeli assault on Gaza, a period characterized by economic instability, credit rating downgrades, and capital flight. By injecting over half a billion dollars in immediate liquidity into the israeli venture capital ecosystem during an active conflict, J&J acted as a "Counter-Cyclical Economic Stabilizer" reinforcing investor confidence in the israeli war economy.OpenIntel: Johnson & Johnson — Executive Dossier (V-Wave $1.7B acquisition during Gaza war)AK&M: Johnson&Johnson completes acquisition of israeli V-Wave for $1.7 billion (August 2024)NEWSru.co.il: FDA Council voted against israeli technology bought by J&J for $600M (December 2025)
4. Partnership with israeli Chief Scientist Office and FutuRx Incubator: In January 2014, Johnson & Johnson Innovation announced the expansion of its global incubator presence through a collaboration with the Office of the Chief Scientist in israel (now israel Innovation Authority), alongside Takeda Pharmaceutical and OrbiMed israel Partners, to establish a biotechnology incubator near Weizmann Science Park in Rehovot. Known as FutuRx, this public-private incubator provides seed funding and support for about 12 companies at a time. The partnership aims to "accelerate the pace of innovation" and "unleash the creativity and entrepreneurship of scientists." J&J also maintains a satellite office near Weizmann Science Park.Johnson & Johnson Official Press Release: J&J Innovation Expands Global Incubator Presence to israel (January 2014)israel Trade: Johnson & Johnson Innovation collaboration with the Office of the Chief Scientist (OCS)OpenIntel: Johnson & Johnson — Political Audit (FutuRx partnership)
5. Investments in israeli Technology Startups: Through its venture arm JJDC (Johnson & Johnson Development Corporation), J&J holds an active portfolio of 12 israeli companies in medical device and biomed sectors. Investments include Orasis Pharmaceuticals ($78 million, October 2024) and DayTwo, which uses gut microbiome sequencing for personalized nutrition advice. J&J has also appointed prominent israeli investors to the JJDC team, including Amir Blatt and Gilad Glick. Moreover, J&J's V-Wave acquisition is part of a broader strategy of capital transfer into the israeli technology ecosystem.IVC Online: Johnson & Johnson Innovation JJDC Inc. — 12 israeli Portfolio CompaniesGlobal Venturing: Which corporates most actively invest in microbiome startups? (DayTwo early backer)OpenIntel: Johnson & Johnson — Economic Audit (JJDC investments)
6. Reliance on Unit 8200-Linked Cybersecurity Vendors: J&J's enterprise security architecture relies on vendors founded by alumni of the IDF's Unit 8200. OpenIntel's Digital Audit confirms the utilization of CyberArk, SentinelOne, Check Point, XM Cyber, and Nice Systems, creating a dependency on israeli "dual-use" technologies for the protection of J&J's intellectual property and patient data. The audit also indicates J&J's engagement with biometric and digital intelligence firms including AnyVision (Oosto) and Cellebrite, technologies often associated with state surveillance and control mechanisms.OpenIntel: Johnson & Johnson — Digital Audit (Unit 8200 Stack, AnyVision/Oosto, Cellebrite)
7. Former VP's Pro-Genocide Statements (November 2023): In November 2023, Sam Maldonado - J&J's former Vice President - posted on Facebook supporting the genocide of Palestinians, describing them as "terrorists who must all be killed" and stating their killing is "obedience to God" because they are "God's chosen people." The statements triggered a global boycott campaign against J&J. Although the post was deleted, J&J issued no official condemnation of it.Dostor: The Full Story of the Boycott Campaign Against Johnson & Johnson (December 2023)
8. Primary Institutional Shareholders: Vanguard and BlackRock - Largest Investors in israeli Weaponry: According to shareholder data, J&J's largest shareholders are BlackRock, Inc. (8.80%) and Vanguard Capital Management, LLC (7.09%). Both firms are explicitly named in an official United Nations report (OHCHR) by Special Rapporteur Francesca Albanese, identified as being "among the largest investors in arms companies pivotal to the genocidal arsenal of israel." Specifically: BlackRock is the second largest institutional investor in Palantir and third largest in Lockheed Martin and Caterpillar; Vanguard is the largest institutional investor in Caterpillar and second largest in Lockheed Martin and Elbit Systems. Consequently, the profits J&J generates flow partly to these two funds, which channel billions of dollars into the weapons industry used by israil in its genocidal war on Gaza.Investing.com: Johnson & Johnson (JNJ) Ownership — BlackRock 8.80%, Vanguard 7.09%Yahoo Finance: Johnson & Johnson Major Holders — Vanguard 9.98%, BlackRock 8.67%UN OHCHR: Report of the Special Rapporteur Francesca Albanese (2025)
9. Stark Double Standards in Crisis Response: J&J issued clear statements on the Ukraine war (March 2022 - suspension of new business in Russia, humanitarian medicine supply to Ukraine), the Black Lives Matter movement (2020 - $100 million commitment), and COVID-19 global access (2021). However, J&J has issued no conflict-specific public statement addressing the israel-Palestine conflict, Gaza hostilities, or Palestinian civilian harm. The company consistently avoids naming Gaza or Palestine in its public statements, offering only an initial $2 million donation response following October 7, 2023.OpenIntel: Johnson & Johnson — Political Audit (Double standards: Russia vs. Gaza)

🌐 Sources

Official and verifiable sources detailing J&J's and its shareholders' involvement with israil:

• OpenIntel: Johnson & Johnson — Executive Dossier (Structural Integration, Tier C, BDS-1000: 603)
• OpenIntel: Johnson & Johnson — Military Audit (Six subsidiaries, Omrix VIGIV, Sheba Medical Center)
• OpenIntel: Johnson & Johnson — Economic Audit (Omrix acquisition, FutuRx, JJDC investments)
• OpenIntel: Johnson & Johnson — Digital Audit (Unit 8200 Stack, AnyVision/Oosto, Cellebrite)
• OpenIntel: Johnson & Johnson — Political Audit (FutuRx partnership, no Gaza statement, double standards)
• Johnson & Johnson Official Press Release: J&J Innovation Expands Global Incubator Presence to israel (January 2014)
• AK&M: Johnson&Johnson completes acquisition of israeli V-Wave for $1.7 billion (August 2024)
• NEWSru.co.il: FDA Council voted against israeli technology bought by J&J for $600M (December 2025)
• IVC Online: Johnson & Johnson Innovation JJDC Inc. — 12 israeli Portfolio Companies
• Dostor: The Full Story of the Boycott Campaign Against Johnson & Johnson (December 2023)
• Investing.com: Johnson & Johnson (JNJ) Ownership — BlackRock 8.80%, Vanguard 7.09%
• UN OHCHR: Report of the Special Rapporteur Francesca Albanese (2025)

Boykot Market has listed the brand information and the final source links verifying the boycott reason above to help you access more details.

Please conduct your own research to be certain. Also, if you find any information incorrect, missing, or erroneous, you can reach us through our contact page. We will get back to you after the necessary reviews.